“… 1 , 7 , 8 , 9 It is hypothesized that H 2 therapy may decrease inflammation by decreasing the cytokine storm and by reducing free radical‐induced damage, which may decrease hypoxia and delay the need for oxygen therapy. 7 , 8 , 9 , 10 , 11 , 12 This hypothesis has led to the initiation of a large‐scale multicenter trial in Europe utilizing hydrogen‐producing tablets in high‐risk patients undergoing ambulatory care. 13 The concept that molecular hydrogen may be a beneficial treatment for severe COVID‐19 is supported by a small trial in China that reported hydrogen inhalation was effective for reducing disease severity and dyspnea.…”